The synthesis of potential pharmacological chaperones and fluorogenic substrates for MPS I, IIIA and VII

2021 ◽  
Author(s):  
◽  
Gareth Doherty
1997 ◽  
Vol 78 (04) ◽  
pp. 1193-1201 ◽  
Author(s):  
Saulius Butenas ◽  
Maria E DiLorenzo ◽  
Kenneth G Mann

SummarySelective, sensitive assays for the quantitation of serine proteases involved in coagulation and fibrinolysis have been developed employing fluorogenic substrates containing a 6-amino-1-naphthalenesulfonamide leaving group (PNS-substrates). Over one hundred substrates were evaluated for hydrolysis by the serine proteases of blood coagulation and fibrinolysis, and substrate structure-efficiency correlations were examined. PNS-substrates which contain Lys in the P1 position are specific for Lys-plasmin and are either not hydrolyzed or hydrolyzed at a relatively low rate by factor Xa, thrombin, or urokinase-type plasminogen activator (uPA). These substrates allow quantitation of Lys-plasmin at concentrations as low as 1 pM. Eighteen of over 90 substrates tested for factor XIa are hydrolyzed by this enzyme at a relatively high rate reaching a kcat value of 170 s-1 and allowing quantitation of factor XIa at 10 fM. Eighteen of almost 90 PNS-substrates tested display high specificity for thrombin, some exceeding that for factor Xa by > 10,000-fold and > 100-fold for activated protein C (APC). Seven of these substrates have a over 100 s-1 and three of them have a KM below 1 μM. They allow the quantitation of thrombin at concentrations as low as 20 fM. For APC, uPA and the factor Vila/tissue factor complex, quantitation is feasible at 1 pM concentration. For factor Xa and factor VIIa the limits are 0.4 pM and 40 pM respectively. The PNS-substrates presented in this study may be employed for the development of direct and sensitive serine protease assays.


PLoS ONE ◽  
2019 ◽  
Vol 14 (12) ◽  
pp. e0220429 ◽  
Author(s):  
Ana Barbosa Mendes ◽  
Cinthia Castro do Nascimento ◽  
Vânia D’Almeida

2016 ◽  
Vol 119 (1-2) ◽  
pp. 124-130 ◽  
Author(s):  
Christian Hinderer ◽  
Peter Bell ◽  
Jean-Pierre Louboutin ◽  
Nathan Katz ◽  
Yanqing Zhu ◽  
...  

1981 ◽  
Vol 110 (1) ◽  
pp. 232-239 ◽  
Author(s):  
Kazuo Murakami ◽  
Tamiko Ohsawa ◽  
Shigehisa Hirose ◽  
Katsumi Takada ◽  
Shumpei Sakakibara

2016 ◽  
Vol 52 (32) ◽  
pp. 5497-5515 ◽  
Author(s):  
Elena M. Sánchez-Fernández ◽  
José M. García Fernández ◽  
Carmen Ortiz Mellet

Recent advancements and future outlook on pharmacological chaperones for lysosomal storage disorders using glycomimetics are discussed.


2014 ◽  
Vol 16 (10) ◽  
pp. 759-765 ◽  
Author(s):  
Michael Beck ◽  
Pamela Arn ◽  
Roberto Giugliani ◽  
Joseph Muenzer ◽  
Torayuki Okuyama ◽  
...  

2001 ◽  
Vol 292 (2) ◽  
pp. 257-265 ◽  
Author(s):  
Vitor Oliveira ◽  
Marcelo Campos ◽  
Jefferson P. Hemerly ◽  
Emer S. Ferro ◽  
Antonio C.M. Camargo ◽  
...  

2008 ◽  
Vol 343 (3) ◽  
pp. 541-548 ◽  
Author(s):  
Mária Vršanská ◽  
Wim Nerinckx ◽  
Marc Claeyssens ◽  
Peter Biely

Sign in / Sign up

Export Citation Format

Share Document